Other key rulings in the Markman hearing concerned terms in CoolTouch's three patents that it has accused Cynosure of infringing. Following the rulings, CoolTouch's infringement claims under two of those patents, U.S. Patent No. 7,217,265 (concerning the treatment of cellulite) and U.S. Patent No. 6,451,007 (concerning post-cooling of tissue), were dismissed with prejudice. Dismissal with prejudice means that CoolTouch cannot bring the same claims against Cynosure again.
"In light of these positive rulings, we look forward to continuing to vigorously defend our IP position as we advance to the next phase of our patent infringement case," Davin said.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.
For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
|SOURCE Cynosure, Inc.|
Copyright©2009 PR Newswire.
All rights reserved